Peritoneovenous Shunting for Intractable Chylous Ascites Complicated with Lymphangioleiomyomatosis

  • Makino Yuko
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Shimanuki Yuri
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Fujiwara Noriko
    Department of Hepatobiliary-Pancreatosurgery, Juntendo University, School of Medicine
  • Morio Yoshiteru
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Sato Koichi
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Yoshimoto Jiro
    Department of Hepatobiliary-Pancreatosurgery, Juntendo University, School of Medicine
  • Gunji Yoko
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Suzuki Tsutomu
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Sasaki Shin-ichi
    The First Division of Internal Medicine, Urayasu Juntendo University Hospital
  • Iwase Akihiko
    Departments of Respiratory Medicine, Tokyo Metropolitan Koto Geriatric Medical Center
  • Kawasaki Seiji
    Department of Hepatobiliary-Pancreatosurgery, Juntendo University, School of Medicine
  • Takahashi Kazuhisa
    Departments of Respiratory Medicine, Juntendo University, School of Medicine
  • Seyama Kuniaki
    Departments of Respiratory Medicine, Juntendo University, School of Medicine

この論文をさがす

抄録

A 38-year-old woman was admitted due to lymphangioleiomyomatosis (LAM)-associated massive chylous ascites and progressive cachexia. She was incidentally diagnosed to have ascites during her regular physical check-up two years previously and LAM was revealed as its underlying cause. Periodic paracentesis was required to ameliorate ascites-associated symptoms, but resulted in lymphocytopenia, malnutrition, and deterioration of general status. Ascites was refractory to diuretics and fat-restricted diet. Peritoneovenous shunt (Denver shunt®) was placed and thereafter ascites has been managed successfully without any complications for one year after the placement. Peritoneovenous shunt should be considered in LAM patients whose chylous ascites can not be managed with conservative treatments.<br>

収録刊行物

  • Internal Medicine

    Internal Medicine 47 (4), 281-285, 2008

    一般社団法人 日本内科学会

被引用文献 (3)*注記

もっと見る

参考文献 (15)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ